Vol 10, Supp. A (2019)
Case report
Published online: 2019-04-26
The effectiveness of ruxolitinib in a patient with primary myelofibrosis
Abstract
Primary myelofibrosis belongs to chronic myeloproliferative neoplasms BCR-ABL1-negative. In this article, we present a case of 74 years-old woman, treated with hydroxyurea at the beginning of the diagnosis. Subsequently, ruxolitinib therapy was started.
Keywords: primary myelofibrosishydroxyurearuxolitinib